# TAUNS Laboratories

> TAUNS Laboratories is a VC fund backing Artificial Intelligence and Medical. See 2 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: Shizuoka, Japan
- Total investments: 2
- Last investment: Aug 2026
- Lead investor: 50%
- Last updated: Sep 2026
- Website: https://www.tauns.co.jp/en

TAUNS Laboratories is a Japanese company specialising in the development, manufacture, and sale of in vitro diagnostics and research reagents, focusing on rapid diagnostic test kits, particularly for infectious diseases such as tuberculosis, influenza, adenovirus, and norovirus.

## Contacts

5 contacts available for TAUNS Laboratories. Shizune tracks 1 team members at TAUNS Laboratories. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/tauns-laboratories?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 2 | 100% |
| Medical | 1 | 50% |
| Oncology | 1 | 50% |
| Analytics | 1 | 50% |
| Health Care | 1 | 50% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series D | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Masaki Nonaka | CEO & President | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Craif | Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for manycancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis. | $24.4M | Series D | Aug 18, 2026 |  |
| EMC Healthcare | EMC Healthcare is a healthcare technology company that provides sensors, nurse calls, and camera security using AI, analytics, and IoT. |  | Series B | Jan 14, 2026 |  |

2 of 2 investments shown.

## Co-investors
- [Granite-Integral](https://shizune.co/investors/profile/granite-integral) — VC Fund, 1 deal together
- [Hokkaido Co-Creation Partners](https://shizune.co/investors/profile/hokkaido-co-creation-partners) — VC Fund, 1 deal together
- [Kodomo no Mori](https://shizune.co/investors/profile/kodomo-no-mori) — VC Fund, 1 deal together
- Nagase Future Fund Investment — VC Fund, 1 deal together
- SUWASHIN Regional Support Fund — VC Fund, 1 deal together
- [Unreasonable](https://shizune.co/investors/profile/unreasonable) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does TAUNS Laboratories invest in?

TAUNS Laboratories invests primarily in Artificial Intelligence, Medical and Oncology startups, most often at Series B and Series D stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact TAUNS Laboratories?

Public channels for TAUNS Laboratories include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at TAUNS Laboratories?

The team at TAUNS Laboratories includes Masaki Nonaka (CEO & President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co